Please login to the form below

Not currently logged in
Email:
Password:

Combination therapies

This page shows the latest Combination therapies news and features for those working in and with pharma, biotech and healthcare.

NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer

NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer

The positive recommendation by NICE should increase clinician confidence in using a combination of therapies in this setting.”.

Latest news

More from news
Approximately 0 fully matching, plus 113 partially matching documents found.

Latest Intelligence

  • A snapshot of… Enterprise Therapeutics A snapshot of… Enterprise Therapeutics

    The company envisages that its drugs will be effective as monotherapies and in combination with other CF therapies including CFTR modulators. ... We are fortunate that Enterprise is well positioned and funded by a combination of private investors and the

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimer’s ahead of a cure

    Many are now coming to the same conclusion: that a combination of different therapies and detection methods could be the answer to fighting Alzheimer’s. ... Alzheimer’s Research UK is launching head first into the fight, with a new drive towards

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    disease. Targeting tau. Tau is among the beneficiaries of the broader focus and emerging interest in combination therapies. ... These mechanisms may be complementary. “We think combination therapies between. antibodies and small molecules make a lot of

  • Combining therapies and combining research Combining therapies and combining research

    create new super-resistant combination therapies. ... This crucial observation was followed by combination therapies for other major disease areas such as AIDS and cancer.

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    Efforts to prevent resistance are also driving interest in combination therapies, said Matthew Galsky, MD, professor of medicine, haematology and medical oncology, Mount Sinai Hospital in New York. ... The risk of autoimmune responses or toxicities, and

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....